Skip to content

Laboratory Corp Of America Holdings

$LHHealthcare Save LH

XNYS · Diagnostics & Research

Last stored close · Nov 10, 2026

Close · Nov 10, 2026

$370.88-0.26%

The live price is free with an account

Model Target

available with Pro

Implied upside

vs the model target

Valuation methods

the methods behind the target

66/100

Positive

QUALITY28VALUE91TECH99RISK49SENT54
Quality & growth28
Valuation91
Technical99
Risk49
Sentiment Signal54

weighted blend of the five model families · nightly cross-sectional scoring · the Sentiment Signal breathes intraday

Laboratory Corp Of America Holdings scores 66 out of 100 overall, which we rate positive. Technical is its strongest area and Quality & growth its weakest.

Computed summary · a narrated read appears after the next narration pass

What helps

  • Technical
  • Valuation
  • Sentiment Signal

What to watch

  • Quality & growth
  • Risk

AI narration of the model output · research, not investment advice · Nov 10, 2026, 21:47 UTC

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

#346 by market cap in our coverage · ~71,000 employees · Listed 1988-07-07 · www.labcorp.com

Price history

LH · 260 stored daily closes · Oct 29, 2025 – Nov 10, 2026+49.5% over the series
$240.00$260.00$280.00$300.00$320.00$340.00$360.00Oct 29, 2025Mar 5, 2026Jul 10, 2026Nov 10, 2026

Intraday to five-year windows are free with an account

Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.

Market intelligence

Peer position

Healthcare

#24 / 139sector rank by TickerWhale Score

TickerWhale Score 66 vs sector average 54.6 (+11.4)

Revenue growth (industry)Top 74%

Gross margin (industry)Top 94%

Return on equity (industry)Top 59%

P/E (industry)Cheaper than 86%

Compare with peers →

Technical analysis

our read · what classic indicators say

99/100Strong vs universe

Ranks 99th of 100 covered names on our technical composite — the composite itself scores 88/100 · 25% of the TickerWhale Score

Buy

4 buy · 3 sell · 1 neutral of 8 votes

Textbook signals on this stock alone — not part of the TickerWhale Score

TickerWhale rates LH's technical setup strong — 99th percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.

9 / 9constructive

  • vs 200-day+27.5%
  • vs 50-day+13.4%

Weak

  • RSI (14)71 · sell
  • Stochasticsell
  • CCIneutral
  • Williams %Rsell

Constructive

  • ADX (14) trend strength48· trending
  • MACD (12,26,9)buy(histogram 2.488)

8 votes · 9 moving averages count as one · Bollinger %B never votes

Strong Sell
Sell
Neutral
▲ Buy
Strong Buy

Moving averages (9) agree on buy — 9 buy vs 0 sell — and carry one vote between them.

Oscillators (7) vote individually: 3 buy · 3 sell · 1 neutral.

Result — 4 buy vs 3 sell of 8 votes = Buy. Neutral votes never decide the verdict.

Across all 17 tracked indicators: 12 buy · 2 neutral · 3 sell — a different count from the 8 votes above, because the 9 averages are counted individually here · true range basis · data as of Nov 10, 2026

Fundamentals & valuation

2026-11-10 · revised_latest
  • P/E (TTM)30.3
  • P/S (TTM)2.1
  • P/B3.5
  • EV/EBITDA—
  • EV/Sales2.5
  • PEG0.91
  • Gross margin28.9%
  • Net margin7.0%
  • ROE11.6%
  • Debt/Equity0.69
  • Revenue growth (YoY)6.4%
  • EPS growth (YoY)33.4%

Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.

Market capitalisation — $30.4B

Fundamentals history

Reported statement totals across recent periods.

No annual statement history is available for this security yet.

Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.

Model Target

Model Target is a Pro feature

Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.

The Model Target is a TickerWhale Pro feature

A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.

Or see the current free one: KNSA →

Peers

CompanyScorePulseP/EP/E fwdP/BEV/SalesPriceChgEstimateUpsideRev. gr.
LHCurrentLaboratory Corp Of America Holdings668830.3—3.52.5$370.88-0.26%+6.4%
EXELExelixis828821.3—9.97.4$70.58-1.62%+9.2%
KNSAKiniksa Pharmaceuticals International plc. -798198.2—12.19.3$95.02-3.79%+58.9%
THCTenet Healthcare798110.9—5.21.6$290.27+0.44%+7.5%
INCYIncyte766715.5—3.93.6$120.30-1.30%+26.9%
LIVNLivaNova768427.2—3.93.3$91.14-1.59%+12.4%

News, sentiment, the Street view and Ask Willy are free with an account

A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.